logo
Share SHARE
FONT-SIZE Plus   Neg

Avon Rejects Coty's Offer - Quick Facts

Beauty company Avon Products, Inc. (AVP) on Monday rejected an an unsolicited, non-binding indication of interest from Coty Inc. to acquire Avon for $23.25 per share.

Coty's indication of interest is non-binding and subject to several conditions such as financing, due diligence and the negotiation of a definitive agreement.

Avon said Coty is attempting to obtain a "free look" at Avon in the absence of any commitment whatsoever to close a transaction at any price.

"Coty's indication of interest of $23.25 per share does not provide a compelling reason for Avon to deviate from its current plans. Under the circumstances, Avon's Board is convinced that rejecting Coty's indication of interest is in Avon shareholders' best interests," the company said.

Avon said its Board of Directors carefully considered the indication of interest from Coty that was substantially the same as one made less than two weeks ago. At that time, the Board concluded, and it still believes, that Coty's indication of interest is opportunistic and not in the best interest of Avon's shareholders.

The Avon Board believes Coty's indication of interest, which offers Avon shareholders only a 20 percent premium over the company's closing share price on March 30, does not reflect the fundamental value of Avon and its global beauty care franchise.

Avon said it is committed to its process of hiring a new CEO and executing against its strong long-term prospects. Avon's Board firmly believes that with a new CEO, there is greater opportunity to improve shareholder value in excess of Coty's conditional indication of interest.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
British drug maker AstraZeneca Plc reported Friday higher profit in its first quarter, reflecting lower charges and higher revenues. US and emerging markets performed well. Looking ahead, for fiscal 2016, the company continues to expect both revenue and earnings per share to decline a low to mid single-digit percentage at constant exchange rates. International Consolidated Airlines Group S.A. Friday reported profit for the first quarter, compared to loss in the prior year, mainly reflecting higher passenger revenues and increased capacity. For fiscal 2016, IAG still expects to generate an absolute operating profit increase similar to 2015 as it expects to reduce underlying ex-fuel unit costs by around one percent. French drug maker Sanofi reported Friday a higher profit in its first quarter, while net sales were hurt mainly by weak results in Diabetes unit and Venezuela. Excluding Venezuela. Aggregate Group sales increased 3 percent at constant exchange rates. Looking ahead, the company continues to expect 2016 business earnings per share to be broadly stable at CER.
comments powered by Disqus
Follow RTT